Mineralocorticoid Receptor Antagonism Attenuates Vascular Apoptosis and Injury via Rescuing Protein Kinase B Activation
Open Access
- 1 February 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 53 (2) , 158-165
- https://doi.org/10.1161/HYPERTENSIONAHA.108.121954
Abstract
Emerging evidence indicates that mineralocorticoid receptor (MR) blockade reduces the risk of cardiovascular events beyond those predicted by its blood pressure–lowering actions; however, the underlying mechanisms remain unclear. To investigate whether protection elicited by MR blockade is through attenuation of vascular apoptosis and injury, independently of blood pressure lowering, we administered a low dose of the MR antagonist spironolactone or vehicle for 21 days to hypertensive transgenic Ren2 rats with elevated plasma aldosterone levels. Although Ren2 rats developed higher systolic blood pressures compared with Sprague-Dawley littermates, low-dose spironolactone treatment did not reduce systolic blood pressure compared with untreated Ren2 rats. Ren2 rats exhibited vascular injury as evidenced by increased apoptosis, hemidesmosome-like structure loss, mitochondrial abnormalities, and lipid accumulation compared with Sprague-Dawley rats, and these abnormalities were attenuated by MR antagonism. Protein kinase B activation is critical to vascular homeostasis via regulation of cell survival and expression of apoptotic genes. Protein kinase B serine 473 phosphorylation was impaired in Ren2 aortas and restored with MR antagonism. In vivo MR antagonist treatment promoted antiapoptotic effects by increasing phosphorylation of BAD serine 136 and expression of Bcl-2 and Bcl-xL, decreasing cytochrome c release and BAD expression, and suppressing caspase-3 activation. Furthermore, MR antagonism substantially reduced the elevated NADPH oxidase activity and lipid peroxidation, expression of angiotensin II, angiotensin type 1 receptor, and MR in Ren2 vasculature. These results demonstrate that MR antagonism protects the vasculature from aldosterone-induced vascular apoptosis and structural injury via rescuing protein kinase B activation, independent of blood pressure effects.This publication has 44 references indexed in Scilit:
- Aldosterone induces mesangial cell apoptosis both in vivo and in vitroAmerican Journal of Physiology-Renal Physiology, 2008
- TGF-β1-induced cardiac myofibroblasts are nonproliferating functional cells carrying DNA damagesExperimental Cell Research, 2008
- Aldosterone and Vascular InflammationHypertension, 2008
- Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertensionCardiovascular Research, 2008
- Loss of Akt1 Leads to Severe Atherosclerosis and Occlusive Coronary Artery DiseaseCell Metabolism, 2007
- Caspase Proteolysis of the Integrin β4 Subunit Disrupts Hemidesmosome Assembly, Promotes Apoptosis, and Inhibits Cell MigrationJournal of Biological Chemistry, 2007
- Spironolactone induces apoptosis and inhibits NF-κB independent of the mineralocorticoid receptorApoptosis, 2006
- Effects of Aldosterone on the VasculatureHypertension, 2006
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Angiotensin and Bradykinin Peptides in the TGR(mRen-2)27 RatHypertension, 1995